» Articles » PMID: 2841098

Induction of Calcitonin Receptors by 1 Alpha, 25-dihydroxyvitamin D3 in Osteoclast-like Multinucleated Cells Formed from Mouse Bone Marrow Cells

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1988 Sep 1
PMID 2841098
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

We have developed a mouse marrow culture system, in which multinucleated cells (MNCs) are formed within 6-8 days. These MNCs showed several characteristics of osteoclasts, including tartrate-resistant acid phosphatase (TRACP) and the ability to resorb calcified dentine. 1 alpha, 25-Dihydroxyvitamin D3 [1 alpha, 25 (OH)2D3] stimulated the formation of TRACP-positive MNCs, and salmon calcitonin (CT) inhibited it. In this study, we examined whether the TRACP-positive MNCs formed from mouse marrow cells possess CT receptors, another typical characteristic of osteoclasts. Mouse marrow cells cultured for 8 days with 10 nM 1 alpha, 25(OH)2D3 and freshly isolated authentic mouse osteoclasts were incubated with [125I]-salmon CT in the presence or absence of excess amounts of unlabeled CT, stained for TRACP, and processed for autoradiography. The [125I]-CT exclusively bound to TRACP-positive mononuclear cells and MNCs formed in the 1 alpha, 25(OH)2D3-treated cultures and also to isolated mouse osteoclasts. Both [125I]-CT binding and TRACP activity were induced simultaneously on mononuclear cells on day 3 in the cultures treated with 1 alpha, 25(OH)2D3. CT markedly stimulated cAMP production in the 1 alpha,25(OH)2D3-treated cultures. The CT-dependent cAMP production increased in parallel with the increase in the number of TRACP-positive MNCs formed. Neither freshly isolated marrow cells nor cells cultured without 1 alpha, 25(OH)2D3 showed CT-induced cAMP accumulation. Furthermore, CT induced cytoplasmic contraction of both marrow-derived MNCs and isolated osteoclasts. These results clearly indicate that 1 alpha,25(OH)2D3 induces TRACP activity and CT receptors almost simultaneously in mouse marrow cultures, and the MNCs formed in vitro respond to CT as authentic osteoclasts do.

Citing Articles

Liraglutide, a glucagon-like peptide-1 receptor agonist, inhibits bone loss in an animal model of osteoporosis with or without diabetes.

Wu Z, Deng W, Ye Y, Xu J, Han D, Zheng Y Front Endocrinol (Lausanne). 2024; 15:1378291.

PMID: 38868747 PMC: 11167098. DOI: 10.3389/fendo.2024.1378291.


The Pathophysiology of Osteoporosis after Spinal Cord Injury.

Shams R, Drasites K, Zaman V, Matzelle D, Shields D, Garner D Int J Mol Sci. 2021; 22(6).

PMID: 33802713 PMC: 8002377. DOI: 10.3390/ijms22063057.


Historically significant events in the discovery of RANK/RANKL/OPG.

Martin T World J Orthop. 2013; 4(4):186-97.

PMID: 24147254 PMC: 3801238. DOI: 10.5312/wjo.v4.i4.186.


Osteoblast-specific overexpression of human interleukin-7 rescues the bone mass phenotype of interleukin-7-deficient female mice.

Aguila H, Mun S, Kalinowski J, Adams D, Lorenzo J, Lee S J Bone Miner Res. 2012; 27(5):1030-42.

PMID: 22258693 PMC: 3361560. DOI: 10.1002/jbmr.1553.


The mouse RANKL gene locus is defined by a broad pattern of histone H4 acetylation and regulated through distinct distal enhancers.

Martowicz M, Meyer M, Pike J J Cell Biochem. 2011; 112(8):2030-45.

PMID: 21465526 PMC: 3135786. DOI: 10.1002/jcb.23123.